Esomeprazole Magnesium
Product Images NDC 50090-4639

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 50090-4639). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
FDA Label Image

Figure 2 Maintenance Of Healing Rates By Month (study 117) (Image 02)

Figure 2 Maintenance Of Healing Rates By Month (study 117) (Image 02)
FDA Label Image

Figure 3 Maintenance Of Healing Rates By Month (study 178) (Image 03)

Figure 3 Maintenance Of Healing Rates By Month (study 178) (Image 03)
The image shows the maintenance of healing rates by month in Study 178 with different doses of Esomeprazole Magnesium Delayed-release Capsules and placebo. The percentage of maintenance is shown on the vertical axis and the different doses are shown on the horizontal axis.*
FDA Label Image

Figure 4 Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Image 04)

Figure 4 Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Image 04)
The text describes a graph titled Figure 4 that shows the percentage of patients who were symptom-free of heartburn by day for a study numbered 225. It shows three bars for Esomeprazole Magnesium Delayed-release Capsules, one with 40mg, one with 20mg and one with a placebo. The x-axis shows the days in the diary, ranging from day 0 to day 28.*
FDA Label Image

Figure 5 Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Image 05)

Figure 5 Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Image 05)
The figure shows the percentage of patients who were symptom-free of heartburn by day in a particular study labeled 226. There were three treatment groups, namely Esomeprazole Magnesium Delayed-release Capsules 40 mg, Esomeprazole Magnesium Delayed-release Capsules 20 mg, and Placebo. The x-axis represents diary days, while the y-axis represents the percentage of patients symptom-free. The figure shows that both doses of Esomeprazole Magnesium Delayed-release Capsules were effective in treating heartburn, and the percentage of patients symptom-free was higher compared to the placebo group. No additional information is available in the given text.*
FDA Label Image

Label Image (Lbl500904639)

Label Image (Lbl500904639)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.